- Celgene's (CELG -10%) mongersen-stoked selloff has engulfed its fellow biotechs.
- Selected tickers: (IBB -1.1%)(XBI +0.1%)(FBT -0.5%)(BBH -1.2%)(BIB -2.3%)(BIIB -2.2%)(AMGN -1.1%)(VRTX -1%)(GILD -1%)
- Previously: Celgene hits bump in road with IBD candidate GED-0301, two studies terminated; shares poised for down move after hours (Oct. 19)